Literature DB >> 24903043

[Pain management in chronic pancreatitis and chronic inflammatory bowel diseases].

J C Preiß1, J C Hoffmann.   

Abstract

Apart from local inflammation and defects in secretion, central mechanisms are important for pain etiology in chronic pancreatitis. Therefore, centrally acting co-analgetic agents can be used in addition to classical pain medications. Endoscopic interventions are preferred in patients with obvious dilation of the pancreatic duct. Surgical interventions are generally more effective although they are usually reserved for patients with prior failure of conservative treatment. Diverse surgical options with different efficacies and morbidities are used in individual patients.One of the main problems in chronic inflammatory bowel diseases is abdominal pain. Primarily the underlying disease needs to be adequately treated. Symptomatic pain management will most likely include treatment with acetaminophen and tramadol as well as occasionally principles of a multimodal pain regimen. For the treatment of arthralgia as well as enteropathy-associated arthritis the same treatment options are available as for other spondyloarthritic disorders.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24903043     DOI: 10.1007/s00482-014-1407-5

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  29 in total

1.  [Updated German guideline on diagnosis and treatment of ulcerative colitis, 2011].

Authors:  A Dignass; J C Preiss; D E Aust; F Autschbach; A Ballauff; G Barretton; B Bokemeyer; S Fichtner-Feigl; S Hagel; K R Herrlinger; G Jantschek; A Kroesen; W Kruis; T Kucharzik; J Langhorst; M Reinshagen; G Rogler; D Schleiermacher; C Schmidt; S Schreiber; H Schulze; E Stange; M Zeitz; J C Hoffmann; A Stallmach
Journal:  Z Gastroenterol       Date:  2011-08-24       Impact factor: 2.000

2.  [S3-Consensus guidelines on definition, etiology, diagnosis and medical, endoscopic and surgical management of chronic pancreatitis German Society of Digestive and Metabolic Diseases (DGVS)].

Authors:  A Hoffmeister; J Mayerle; C Beglinger; M W Büchler; P Bufler; K Dathe; U R Fölsch; H Friess; J Izbicki; S Kahl; E Klar; J Keller; W T Knoefel; P Layer; M Loehr; R Meier; J F Riemann; M Rünzi; R M Schmid; A Schreyer; B Tribl; J Werner; H Witt; J Mössner; M M Lerch
Journal:  Z Gastroenterol       Date:  2012-11-13       Impact factor: 2.000

Review 3.  Treatment for painful calcified chronic pancreatitis: extracorporeal shock wave lithotripsy versus endoscopic treatment: a randomised controlled trial.

Authors:  Jean-Marc Dumonceau; Guido Costamagna; Andrea Tringali; Kouroche Vahedi; Myriam Delhaye; Axel Hittelet; Gianluca Spera; Emiliano Giostra; Massimiliano Mutignani; Viviane De Maertelaer; Jacques Devière
Journal:  Gut       Date:  2006-10-17       Impact factor: 23.059

Review 4.  Understanding and treating abdominal pain and spasms in organic gastrointestinal diseases: inflammatory bowel disease and biliary diseases.

Authors:  Govind K Makharia
Journal:  J Clin Gastroenterol       Date:  2011-08       Impact factor: 3.062

5.  Effect of tramadol and morphine on pain and gastrointestinal motor function in patients with chronic pancreatitis.

Authors:  C H Wilder-Smith; L Hill; W Osler; S O'Keefe
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

6.  Pain management in patients with inflammatory bowel disease: insights for the clinician.

Authors:  Arvind Iyengar Srinath; Chelsea Walter; Melissa C Newara; Eva M Szigethy
Journal:  Therap Adv Gastroenterol       Date:  2012-09       Impact factor: 4.409

7.  Pregabalin reduces pain in patients with chronic pancreatitis in a randomized, controlled trial.

Authors:  Søren Schou Olesen; Stefan A W Bouwense; Oliver H G Wilder-Smith; Harry van Goor; Asbjørn Mohr Drewes
Journal:  Gastroenterology       Date:  2011-04-14       Impact factor: 22.682

8.  The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases.

Authors:  Yasser El Miedany; Sally Youssef; Ihab Ahmed; Maha El Gaafary
Journal:  Am J Gastroenterol       Date:  2006-02       Impact factor: 10.864

Review 9.  Methotrexate for ankylosing spondylitis.

Authors:  Junmin Chen; Mirella M S Veras; Chao Liu; Junfang Lin
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

Review 10.  Physiotherapy interventions for ankylosing spondylitis.

Authors:  H Dagfinrud; T K Kvien; K B Hagen
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23
View more
  1 in total

1.  [Visceral pain. Still a poor relation of pain medicine?].

Authors:  W Jänig; W Häuser
Journal:  Schmerz       Date:  2014-06       Impact factor: 1.107

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.